Würzburg, Germany and Utrecht, the Netherlands
The nuclear cardiology core facility of the CHFC-Würzburg has acquired MILabs E-class SPECT/CT system to enhance its existing top-level basic, translational and clinical research activities in the field of heart failure. Upgradeable with simultaneous PET imaging, the E-Class SPECT/CT system combines economic use with exceptional translational imaging performance. The system features list mode based simultaneous high-resolution multi-isotope gated cardiac imaging capabilities – a critical performance feature for gaining better insights into, e.g. cardiac neuronal and vascular biology.
With an estimated 3 million heart failure patients in Germany and over 30 million worldwide, the CHFC- Würzburg uses world-class multi-disciplinary research for the development of new therapeutic strategies, which intervene early in the healing and remodeling processes of the heart.
Prof. Dr. Takahiro Higuchi, Head of Pre-Clinical Imaging comments:” The use of high-end SPECT imaging fused with the anatomical structure of the heart obtained with low-dose CT is essential for translational cardiology imaging. For instance, one can uniquely visualize cardiac sympathetic nervous activity with this high-resolution nuclear imaging technique.
According to Prof. F. Beekman, founder & CEO of MILabs B.V.:” We are delighted to collaborate with Dr. T. Higuchi’s team to optimize the performance of our multimodality E-Class imaging system for cardiac applications. Because of the high spatial and temporal resolution of our nuclear imaging technologies, the system allows both global as well as regional functional and dynamic kinetic analysis. Once upgraded with PET, by eliminating positron range blurring, the system enables, for the first time, murine cardiac imaging with 82Rb, a popular PET tracer used in the clinic.”
About the Comprehensive Heart Failure Center (CHFC):
The CHFC is the heart research center of the Medical Faculty of the University of Würzburg. The CHFC in one out of eight German integrated research and treatment centers. It is the only center focused on heart failure disease, and the institute uses a comprehensive, multidisciplinary approach to research and treat illness. Within its large 5500 m2 new building on the campus of the University Clinic Wuerzburg, the center has four “Core facilities” – imaging, genetics, translational research, and clinical research & epidemiology, which provide modern and high-performance equipment and specialized personal expertise to both internal and external research groups. For more information, visit: https://www.ukw.de/clinical-profile-centers/comprehensive-heart-failure-center-chfc/home/
About MILabs B.V.
The company has a history of providing a continuum of innovations to expand the applications of its multimodality imaging solutions used for the development of new diagnostic solutions and therapies. With its latest adaptive preclinical platform, MILabs has succeeded at commercializing a scalable imaging platform, able to accommodate PET, SPECT, Optical and CT imaging in a single integrated and user-friendly system. Awarded the Commercial Innovation of the Year 2018 at the Molecular Imaging Congress, this platform is globally recognized for being able to deliver the highest quality molecular, functional and anatomical images. For more information, visit: www.milabs.com or contact MILabs at [email protected]